ArticleHuman vaccines & immunotherapeutics2022

Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population.

Kriangkrai Tawinprai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.